Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

David E Gerber

Clinical trials sponsored by David E Gerber, explained in plain language.

Not yet finished but already full! 1

New hope for Tough-to-Treat lung cancer? experimental drug targets KRAS mutation

Disease control Ongoing

This study is testing an experimental oral drug called TVB-2640 in people with advanced non-small cell lung cancer that has a specific genetic change called a KRAS mutation and has stopped responding to standard treatments. The main goals are to see if the drug can control the ca…

Phase: PHASE2 • Sponsor: David E Gerber • Aim: Disease control

Last updated Mar 31, 2026 12:12 UTC